APIF: A new interaction fingerprint based on atom pairs and Its application to virtual screening

Journal of Chemical Information and Modeling

Volumn 49, Issue 5, 2009, Pages 1245-1260

  Perez Nueno, Violeta I ^a   Rabal, Obdulia ^a   Borrell, José I ^a   Teixido, Jordi ^a  

^a INSTITUT QUÍMIC DE SARRIÀ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY;

CARBOXYPEPTIDASE; DOCKING SOLUTIONS; ENRICHMENT FACTORS; ESTROGEN RECEPTOR; ITS APPLICATIONS; PROTEIN-LIGAND DOCKING; RELATIVE POSITIONS; VIRTUAL SCREENING;

ATOMS;

EID: 66249123260     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci900043r     Document Type: Article

References (30)

1. Deng, Z.; Chuaqui, C.; Singh, J. Structural interaction fingerprint (SIFt): A novel method for analyzing three-dimensional protein-ligand binding interactions. J. Med. Chem. 2004, 47, 337-344.
2. Kelly, M. D.; Mancera, R. L. Expanded interaction fingerprint method for analyzing ligand binding modes in docking and structure-based drug design. J. Chem. Inf. Comput. Sci. 2004, 44, 1942-1951.
3. Mpamhanga, C. P.; Chen, B.; McLay, I. M.; Willett, P. Knowledge-based interaction fingerprint scoring: a simple method for improving the effectiveness of fast scoring functions. J Chem lnf Model. 2006, 46, 686-698.
4. Chuaqui, C.; Deng, Z.; Singh, J. Interaction Profiles of Protein Kinase-Inhibitor Complexes and Their Application to Virtual Screening. J. Med. Chem. 2005, 48, 121-133.
5. Warren, G. L.; Andrews, C. V.; Capelli, A.; Clarke, B.; LaLonde, J.; Lambert, M. H.; Lindvall, M.; Nevins, N.; Semus, S. F.; Senger, S.; Tedesco, G.; Wall, I. D.; Woolven, J. M.; Peishoff, C. E.; Head, M. S. A critical assessment of docking programs and scoring functions. J. Med. Chem. 2006, 49, 5912-5931.
6. Taylor, R. D.; Jewsbury, P. J.; Essex, J. W. A Review of Protein-Small Molecule Docking Methods. J. Comput.-Aided. Mol. Des. 2002, 16, 151-166.
7. Carhart, R. E.; Smith, D. H.; Venkataraghavan, R. Atom Pairs as Molecular Features in Structure-Activity Studies: Definitions and Applications. J. Chem. Inf. Comput. Sci. 1985, 25, 64-73.
8. FlexS-77 data set collected by C. Lemmen, G. Klebe, and M. Bohm, first published in: Lemmen, C.; Lengauer, T; Klebe, G. FlexS: A Method for Fast Flexible Ligand Superposition. J. Med. Chem. 1998, 41, 4502-4520.
9. Bissantz, C.; Folkers, G.; Rognan, D. Protein-Based Virtual Screening of Chemical Databases. 1. Evaluation of Different Docking/Scoring Combinations. J. Med. Chem. 2000, 43, 4759-4767.
10. Maybride Bringing Life to Drug Discovery; Maybridge Databases Autumn 2005; Fisher Scientific International: England, 2005.
11. MOE (Molecular Operating Environment), 2006.08 release; Chemical Computing Group, Inc.: Montreal, Canada, 2004.
12. Verdonk, M. L.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.; Taylor, R. D. Virtual screening using protein-ligand docking: avoiding artificial enrichment. J. Chem. Inf. Comput. Sci. 2004, 44, 793-806.
13. Verdonk, M. L.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.; Taylor, R. D. Improved Protein-Ligand Docking Using GOLD. Proteins: Struct., Funct., Genet. 2003, 52, 609-623.
14. Marquart, M.; Walter, J.; Deisenhofer, J.; Bode, W.; Huber, R. The Geometry of the Reactive Site and of the Peptide Groups in Trypsin, Trypsinogen and its Complexes with Inhibitors. Acta Crystallogr., Sect. B 1983, 39, 480-490.
15. Renatus, R.; Bode, W.; Huber, R.; Sturzebecher, J.; Stubbs, M. T. Structural and Functional Analyses of Benzamidine-Based Inhibitors in Complex with Trypsin: Implications for the Inhibition of Factor Xa, tPA, and Urokinase. J. Med. Chem. 1998, 41, 5445-5456.
16. Bohm, M.; Sturzebecher, J.; Klebe, G. Three-Dimensional Quantitative Structure-Activity Relationship Analyses Using Comparative Molecular Field Analysis and Comparative Molecular Similarity Indices Analysis To Elucidate Selectivity Differences of Inhibitors Binding to Trypsin, Thrombin, and Factor Xa. J. Med. Chem. 1999, 42, 458-477.
17. Badger, J.; Minor, I.; Oliveira, M. A.; Smith, T. J.; Rossmann, M. G. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. Proteins 1989, 6, 1-19.
18. Matthews, D. A.; Dragovich, P. S.; Webber, S. E.; Fuhrman, S. A.; Patick, A. K.; Zalman, L. S.; Hendrickson, T. F.; Love, R. A.; Prins, T. J.; Marakovits, J. T.; Zhou, R.; Tikhe, J.; Ford, C. E.; Meador, J. W.; Ferre, R. A.; Brown, E. L.; Binford, S. L.; Brothers, M. A.; DeLisle, D. M.; Worland, S. T. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 11000-11007.
19. Bone, R.; Vacca, J. P.; Anderson, P. S.; Holloway, M. K. X-Ray Crystal Structure of the HIV Protease Complex with L-700,417, an Inhibitor with Pseudo C2 Symmetry. J. Am. Chem. Soc. 1991, 113, 9382-9384.
20. Specker, E.; Bottcher, J.; Brass, S.; Heine, A.; Lilie, H.; Schoop, A.; Muller, G.; Griebenow, N.; Klebe, G. Unexpected Novel Binding Mode of Pyrrolidine-Based Aspartyl Protease Inhibitors: Design, Synthesis and Crystal Structure in Complex with HIV Protease. ChemMedChem 2006, 1, 106-117.
21. Specker, E.; Bottcher, J.; Lilie, H.; Heine, A.; Schoop, A.; Muller, G.; Griebenow, N.; Klebe, G. An Old Target Revisited: Two New Privileged Skeletons and an Unexpected Binding Mode For HIV-Protease Inhibitors. Angew. Chem., Int. Ed. 2005, 44, 3140-3144.
22. Teplyakov, A.; Wilson, K. S.; Orioli, P.; Mangani, S. High-resolution structure of the complex between carboxypeptidase A and L-phenyl lactate. Acta Crystallogr. Sect., D 1993, 49, 534-540.
23. Rees, D. C.; Lipscomb, W. N. Binding of ligands to the active site of carboxypeptidase A. Proc. Natl Acad. Sci. U. S. A. 1981, 78, 5455-5459.
24. Kim, H.; Lipscomb, W. N. Crystal Structure of the Complex of Carboxypeptidase A with a Strongly Bound Phosphonate in a New Crystalline Form: Comparison with Structures of Other Complexes. Biochemistry 1990, 29, 5546-5555.
25. Christianson, D. W.; Lipscomb, W. N. Binding of a possible transition state analogue to the active site of carboxypeptidase A. Proc. Natl. Acad. Sci. U. S. A. 1985, 82, 6840-6844.
26. Shiau, A. K.; Barstad, D.; Loria, P. M.; Cheng, L.; Kushner, P. J.; Agard, D. A.; Greene, G. L. The structural basis of estrogen receptor/ coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95, 927-937.
27. Mason, J. S.; Morize, I.; Menard, P. R.; Cheney, D. L.; Hulme, C.; Labaudiniere, R. F. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. J. Med. Chem. 1999, 42, 3251-3264.
28. Willet, P. Chemical Similarity Searching. J. Chem. Inf. Comput. Sci. 1996, 36, 900-908.
29. Hert, J.; Willet, P.; Wilton, D. J. Comparison of Fingrprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures. J. Chem. Inf. Comput. Sci. 2004, 44, 1177-1185.
30. Marcou, G.; Rognan, D. Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints. J. Chem. Inf. Model. 2007, 47, 195-207.